je.st
news
Tag: pediatric
Clinicial Software streamlines pediatric reporting workflows.
2014-06-03 14:30:56| Industrial Newsroom - All News for Today
Cardiovascular Information System (CVIS) Solutions include SMART (Structured Macros And Report Templates) feature, which accelerates creation of entire report template via intuitive, structured workflow. Clinicians can complete reports with few clicks and without requiring multiple forms. Also, database fields can be autopopulated directly into report templates. Feature comes with list of configurable congenital macros/templates while offering configurability and supporting full data mining. This story is related to the following:Medical & Health Care Software | Content Management Software |
Tags: software
reporting
pediatric
workflows
BIO and ViS Research Expand Research Site Group to Help Streamline Pediatric Clinical Trials
2014-05-07 06:00:00| Industrial Newsroom - All News for Today
BIO and ViS Research (ViS) announced Pediatric Clinical Research Group on ViS platform will include pediatric research sites. Launched to improve efficacy of clinical development for pediatric therapeutics, initiative aims to help member companies more efficiently assess global pediatric clinical research landscape and engage sites more easily for pediatric clinical studies. Initiative will also enable mapping of pediatric patient population and reduce site burden from feasibility ...This story is related to the following:Trade Associations
Tags: site
group
research
expand
Axalta\'s Brilliant Flames Bedazzle Jeff Gordon Pediatric Treatment Room
2014-04-14 07:00:00| Coatings World Breaking News
Tags: room
treatment
jeff
gordon
Merck Receives FDA Approval for ISENTRESS (raltegravir) for Pediatric Oral Suspension
2014-01-08 14:30:00| Merck.com - Product News
Dateline City: WHITEHOUSE STATION, N.J. WHITEHOUSE STATION, N.J.--(BUSINESS WIRE)--Merck (NYSE:MRK), known as MSD outside the United States and Canada, announced today that the U.S. Food and Drug Administration (FDA) recently approved ISENTRESS for oral suspension, a new pediatric formulation of Mercks integrase inhibitor. With this approval, ISENTRESS is now indicated in combination with other antiretroviral (ARV) agents for the treatment of HIV-1 infection in patients four weeks of age and older. Language: English Contact: MerckMedia:Pam Eisele, 267-305-3558orSarra Herzog, 908-423-6154orInvestors:Carol Ferguson, 908-423-4465orJustin Holko, 908-423-5088 Ticker Slug: Ticker: MRK Exchange: NYSE read more
Tags: approval
oral
receives
suspension
Digisonics and Medis Partner to Provide Comprehensive Pediatric and Adult Cardiovascular MR ...
2013-12-19 06:00:00| Industrial Newsroom - All News for Today
HOUSTON – Digisonics and Medis are proud to announce a partnership to provide a comprehensive single system solution for image analysis and structured reporting of pediatric and adult CV MR studies. The integrated system solution between Digisonics and Medis will result in a seamless, efficient MR workflow.<br /> <br /> Users will have access to fast image review and analysis of their MR studies via the Medis QMass® ES advanced quantitation software which provides built-in ...This story is related to the following:Vision SystemsMedical & Health Care Software | Data Analysis Software |
Tags: provide
partner
mr
adult